CNS PharmaceuticalsCNSP
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$2.25avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding CNS Pharmaceuticals Inc. (CNSP) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Sound Income Strategies, LLC ($36).
- Company
- CNS Pharmaceuticals Inc.
- CUSIP
- 18978H409
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Sound Income Strategies, LLC | 0.00% | No change | 16 | $36 |
"% of holder's portfolio" is CNSP's weight in each manager's 13F, not the share of CNS Pharmaceuticals Inc. the manager owns.